понедельник, 13 марта 2017 г.

Celgene Co. (CELG) Price Target Increased to $155.00 by Analysts at Jefferies Group LLC

Celgene Co. (CELG) Price Target Increased to $155.00 by Analysts at Jefferies Group LLC


The brokerage presently has a "buy" rating on the biopharmaceutical company's stock. Jefferies Group LLC's target price would indicate a potential upside of 25.00% from the company's current price.



from Biotech News